Germantown, Md.
Qiagen Sciences is completing a 190,000-sf facility in Germantown, where the company is licensed to manufacture products resulting from the collaboration of Seattle-based Qiagen Genomics and The Institute for Genomic Research in Rockville, Md., on tuberculosis strains. Qiagen Genomics' parent company is Germany-based Qiagen.
